Yiwei Liu

851 total citations
41 papers, 529 citations indexed

About

Yiwei Liu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yiwei Liu has authored 41 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yiwei Liu's work include Lung Cancer Treatments and Mutations (7 papers), Acute Lymphoblastic Leukemia research (6 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Yiwei Liu is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Acute Lymphoblastic Leukemia research (6 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Yiwei Liu collaborates with scholars based in China, United States and Japan. Yiwei Liu's co-authors include Shengxiang Ren, Bingzheng Liu, Tao Jiang, Caicun Zhou, Chunxia Su, Terry L. Ng, Seth E. Karol, Mary V. Relling, Sima Jeha and John C. Panetta and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Cancer.

In The Last Decade

Yiwei Liu

40 papers receiving 525 citations

Peers

Yiwei Liu

ONCOL

PRM

PHEOH

PPCH

Yoichi Kakuta Japan

Clemens Grupp Germany

Bimin Shi China

G St-Louis Canada

Jeong Hyun Kim South Korea

Noël Knops Belgium

Shigeru Kohno Japan

David J. Reeves United States

Nathan A. Brooks United States

Julie Bellière France

Yoichi Kakuta Japan

Yiwei Liu

150 ×0.9

ONCOL

115 ×0.7

PRM

129 ×1.3

111 ×1.3

PHEOH

52 ×0.7

PPCH

Citations per year, relative to Yiwei Liu Yiwei Liu (= 1×) peers Yoichi Kakuta

Countries citing papers authored by Yiwei Liu

Since Specialization

Citations

This map shows the geographic impact of Yiwei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiwei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiwei Liu more than expected).

Fields of papers citing papers by Yiwei Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiwei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiwei Liu. The network helps show where Yiwei Liu may publish in the future.

Co-authorship network of co-authors of Yiwei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yiwei Liu. A scholar is included among the top collaborators of Yiwei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiwei Liu. Yiwei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Rixiang, Hao Wang, Yiwei Liu, et al.. (2025). Using open GPS trajectory data to quantify nature-based recreation at a national scale. Resources Conservation and Recycling. 220. 108340–108340.

Liu, Yiwei, et al.. (2024). Association of duration of intrapartum maternal hyperglycemia in well-controlled gestational diabetes mellitus women and risks of neonatal hypoglycemia: a retrospective cohort study. The Journal of Maternal-Fetal & Neonatal Medicine. 38(1). 2431617–2431617. 2 indexed citations

Han, Ruoshuang, Haoyue Guo, Jinpeng Shi, et al.. (2024). Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer. BMC Medicine. 22(1). 174–174. 11 indexed citations

Liu, Yiwei, Yifan Wang, Run Dong, et al.. (2024). A nationwide study on new onset atrial fibrillation risk factors and its association with hospital mortality in sepsis patients. Scientific Reports. 14(1). 12206–12206. 3 indexed citations

Wu, Jinlin, Mohammad A. Zafar, Yiwei Liu, et al.. (2023). Fate of the unoperated ascending thoracic aortic aneurysm: three-decade experience from the Aortic Institute at Yale University. European Heart Journal. 44(43). 4579–4588. 31 indexed citations

Shao, Ke, Hui Shen, Xiaofeng Chen, et al.. (2022). Copper transporter gene ATP7A: A predictive biomarker for immunotherapy and targeted therapy in hepatocellular carcinoma. International Immunopharmacology. 114. 109518–109518. 8 indexed citations

Liu, Yiwei, et al.. (2022). The Implementation and Assessment of a Perioperative Co-Management of Surgical Services Rotation for Medical Students. Journal of surgical education. 79(5). 1099–1102. 2 indexed citations

Mao, Shiqi, Fei Zhou, Yiwei Liu, et al.. (2021). ICI plus chemotherapy prolonged survival over ICI alone in patients with previously treated advanced NSCLC. Cancer Immunology Immunotherapy. 71(1). 219–228. 7 indexed citations

Panetta, John C., Yiwei Liu, Teodoro Bottiglieri, et al.. (2021). Pharmacodynamics of cerebrospinal fluid asparagine after asparaginase. Cancer Chemotherapy and Pharmacology. 88(4). 655–664. 7 indexed citations

10.

Yu, Xiaofei, Zhengwei Dong, Wanying Wang, et al.. (2021). Adenocarcinoma of High-Grade Patterns Associated with Distinct Outcome of First-Line Chemotherapy or EGFR-TKIs in Patients of Relapsed Lung Cancer. Cancer Management and Research. Volume 13. 3981–3990. 4 indexed citations

11.

Karol, Seth E., Deqing Pei, Colton A. Smith, et al.. (2021). Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy. Haematologica. 107(2). 371–380. 8 indexed citations

12.

Liu, Yiwei, Wanying Wang, Fengying Wu, et al.. (2021). High discrepancy in thrombotic events in non-small cell lung cancer patients with different genomic alterations. Translational Lung Cancer Research. 10(3). 1512–1524. 20 indexed citations

13.

Nie, Xiaolu, Ziyang Song, Xuan Zhang, et al.. (2020). Signal Detection of Potentially Drug-Induced Liver Injury in Children Using Electronic Health Records. Frontiers in Pediatrics. 8. 171–171. 9 indexed citations

14.

Liu, Yiwei, Yingying Wang, Xinming Wang, et al.. (2020). Development of two TaqMan real-time reverse transcription-PCR assays for the detection of severe acute respiratory syndrome coronavirus-2. Biosafety and Health. 2(4). 232–237. 11 indexed citations

15.

Liu, Yiwei, Daisuke Sugiyama, Aya Hirata, et al.. (2019). Abstract 11254: Double Product Privilege in Predicting All-cause and Cardiovascular Disease Mortality Compare to Heart Rate and Blood Pressure Separately, the Nippon-data 80 Study. Circulation. 1 indexed citations

16.

Jia, Yijun, Sha Zhao, Tao Jiang, et al.. (2019). Impact of EGFR-TKIs combined with PD-L1 antibody on the lung tissue of EGFR-driven tumor-bearing mice. Lung Cancer. 137. 85–93. 23 indexed citations

17.

Yang, Yan, et al.. (2018). Epidemiology of Malaria in Yulin, South China 1999–2016: Imported Malaria Threatens Zero Local Case Status. Vector-Borne and Zoonotic Diseases. 18(10). 533–538. 7 indexed citations

18.

Ren, Shengxiang, Hui Yu, Christopher J. Rivard, et al.. (2018). The immune checkpoint, HVEM may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expression. Lung Cancer. 125. 115–120. 38 indexed citations

19.

Wu, Wei, et al.. (2015). Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens. European Journal of Clinical Pharmacology. 72(1). 29–37. 30 indexed citations

20.

Liu, Yiwei, et al.. (1994). A new mathematical model of hypothalamo-pituitary-thyroid axis. Mathematical and Computer Modelling. 19(9). 81–90. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact